• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVI

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2021 Apr 20;21(1):371.
doi: 10.1186/s12879-021-06057-z.
The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients


Liulin Wang[SUP] 1 2 [/SUP], Xiaobin Cheng[SUP] 1 2 [/SUP], Qiufen Dong[SUP] 1 2 [/SUP], Chenliang Zhou[SUP] 3 [/SUP], Yeming Wang[SUP] 4 [/SUP], Bin Song[SUP] 5 [/SUP], Weinan Li[SUP] 2 6 [/SUP], Min Wang[SUP] 1 2 [/SUP], Rui Qin[SUP] 1 2 [/SUP], Qi Long[SUP] 1 2 [/SUP], Juan Liu[SUP] 1 2 [/SUP], Jing Li[SUP] 1 2 [/SUP], Dan Li[SUP] 1 2 [/SUP], Gang Li[SUP] 7 8 [/SUP], Yuanming Ba[SUP] 9 10 [/SUP]



Affiliations

Abstract

Background: The current coronavirus disease 2019 (COVID-19) is a public health emergency. In this study, we aimed to evaluate the risk factors for mortality in severe and critical COVID-19 patients.
Methods: We performed a retrospective study of patients diagnosed with severe and critical COVID-19 from four hospitals in Wuhan, China, by evaluating the clinical characteristics and laboratory results, and using Cox proportional hazards model to assess the risk factors involved in disease progression.
Results: In total, 446 patients with COVID-19 were enrolled. The study indicated a high mortality rate (20.2%) in severe and critical COVID-19 patients. At the time of admission, all patients required oxygen therapy, and 52 (12%) required invasive mechanical ventilation, of which 50 (96%) died. The univariate Cox proportional hazards model showed a white blood cell count of more than 10 ? 10[SUP]9[/SUP]/L (HR 3.993,95%CI 2.469 to 6.459) that correlated with an increased mortality rate. The multivariable Cox proportional hazards model demonstrated that older age (HR 1.066, 95% CI 1.043 to 1.089) and higher white blood cell count (HR 1.135, 95% CI 1.080 to 1.192) were independent risk factors for determining COVID-19 associated mortality.
Conclusions: COVID-19 is associated with a significant risk of morbidity and mortality in the population. Older age and higher white blood cell count were found to be independent risk factors for mortality.

Keywords: COVID-19; Cox proportional hazards model; Laboratory tests; Risk factors.
 
Back
Top Bottom